Neurology News

The American Brain Foundation has announced the launch of a $10 million cross-disciplinary research initiative for neuroscientists to investigate the role of neuroinflammation in a wide range of neurologic and psychiatric brain diseases.

An integrated carotid artery stent system was associated with the lowest 1-year event rates in any well-powered, multicenter carotid revascularization trial, according to data presented at VIVA.23.

The FDA has cleared an investigational new drug application for AVB-101 to treat those with frontotemporal dementia with mutations in the progranulin gene, according to a release from the manufacturer.

A Canadian neuroimaging company has received an investment from the Alzheimer’s Drug Discovery Foundation to accelerate development of novel biomarkers for Alzheimer’s disease and related dementias.

Sexual and gender minority health care in child neurology is “such an important topic that just hasn’t gotten enough attention,” according to Ariel Maia Lyons-Warren, MD, PhD.

Ariel Maia Lyons-Warren, MD, PhD, an instructor of child neurology at Baylor College of Medicine and Texas Children’s Hospital, discusses what stood out to her at the Child Neurology Society annual meeting in Vancouver.

A small-molecule chemotherapeutic did not improve efficacy compared with standard therapies in adults with glioblastoma, according to the manufacturer.

Nido Biosciences has announced positive results from a phase 1 study of its novel, small molecule therapeutic to treat spinal and bulbar muscular atrophy in healthy male participants.

In a position statement published in the Journal of Clinical Sleep Medicine, the American Academy of Sleep Medicine has issued an updated recommendation that the United States shift to permanent standard time.

A Bay Area neurotechnology firm has announced the commercial release of a novel artificial intelligence-based software algorithm that continuously monitors brain activity of those with electrographic status epilepticus.